Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor
Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
Pharma News

GSK, Sanofi and Haleon ‘facing billions of dollars in Zantac liability’

Pharma News

3rd TIGIT Axis Therapies Summit

Pharma News

Novartis’ Pluvicto gets first European approval in GB

Pharma News

Challenges and opportunities in the off-patent sector: the pharmaphorum podcast

Pharma News

COVID antibody declines prompts call for booster jabs ASAP

Pharma News

New malnutrition reporting measure available for reporting

Pharma News

Sanofi pauses enrolment in ex-US tolebrutinib trials

Pharma News

Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares

Pharma News

Merck swings back into Alzheimer’s with $1.1bn Cerevance alliance

Pharma News

AZ and Daiichi’s TROP2 ADC shows promise in first-line lung cancer

Pharma News

Eisai steps up beyond-the-pill approach to dementia in Japan

Pharma News

BMS adds to IBD pipeline with $1.9bn GentiBio deal

Latest news

  • Pharma News

    GSK, Sanofi and Haleon ‘facing billions of dollars in Zantac liability’

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    GSK, its consumer health spin-off Haleon and Sanofi could be on the hook for billions…

    Read more
  • Pharma News

    3rd TIGIT Axis Therapies Summit

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    The 3rd TIGIT Axis Therapies Summit returns to unite large pharma, innovative biotechs and pioneering academics…

    Read more
  • Pharma News

    Novartis’ Pluvicto gets first European approval in GB

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    Novartis has secured its first approval in Europe for prostate cancer radioligand therapy Pluvicto, getting…

    Read more
  • Pharma News

    Challenges and opportunities in the off-patent sector: the pharmaphorum podcast

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock welcomes Rebecca Guntern, vice…

    Read more
  • Pharma News

    COVID antibody declines prompts call for booster jabs ASAP

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    Figures from the UK Office for National Statistics (ONS) have revealed that the number of…

    Read more
  • Pharma News

    New malnutrition reporting measure available for reporting

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    The innovative Global Malnutrition Composite Score, approved by Centers for Medicare & Medicaid Services (CMS),…

    Read more
  • Pharma News

    Sanofi pauses enrolment in ex-US tolebrutinib trials

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    Sanofi has paused recruitment in its international phase 3 trials of BTK inhibitor tolebrutinib for…

    Read more
  • Pharma News

    Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    Cancer Research UK is working with global biopharma Sosei Heptares on a treatment they hope…

    Read more
  • Pharma News

    Merck swings back into Alzheimer’s with $1.1bn Cerevance alliance

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    Merck & Co’s earlier efforts to find new therapies for Alzheimer’s disease resulted in failure,…

    Read more
  • Pharma News

    AZ and Daiichi’s TROP2 ADC shows promise in first-line lung cancer

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo’s TROP2-targeting…

    Read more
  • Pharma News

    Eisai steps up beyond-the-pill approach to dementia in Japan

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    More and more pharma companies are looking “beyond the pill” when it comes to providing…

    Read more
  • Pharma News

    BMS adds to IBD pipeline with $1.9bn GentiBio deal

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel…

    Read more
  • Pharma News

    How Pharmacogenomics may finally realise its promise

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    More than 60 percent of all American adults take prescription drugs, amounting to approximately 131…

    Read more
  • Pharma News

    Abecma hits the mark in earlier-stage multiple myeloma

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    Bristol-Myers Squibb is on course to move its BCMA-targeting CAR-T therapy further up the treatment…

    Read more
  • Pharma News

    Digital health firm Biofourmis adds another $20m to its funding pot

    by Stephen Riddle August 11, 2022
    by Stephen Riddle August 11, 2022

    One of the digital health sector’s latest unicorn companies – Biofourmis – has upscaled its…

    Read more
  • Pharma News

    The Rise of Influencer Marketing: How Patient Leaders Bring Value to Campaigns

    by Stephen Riddle August 9, 2022
    by Stephen Riddle August 9, 2022

    Social health—the dynamic, real-time action people take to find meaningful connections and share information that…

    Read more
  • Pharma News

    Koneksa aims to answer Parkinson’s-tracking challenge with AI

    by Stephen Riddle August 9, 2022
    by Stephen Riddle August 9, 2022

    Healthcare technology firm Koneksa will carry out a study to evaluate whether digital biomarkers can…

    Read more
  • Pharma News

    Verona cues up filings for COPD drug after it aces phase 3 test

    by Stephen Riddle August 9, 2022
    by Stephen Riddle August 9, 2022

    UK-based Verona Pharma has scored a key win in a phase 3 trial of its…

    Read more
  • Pharma News

    Tagrisso paired with Hutchmed drug clears lung cancer test

    by Stephen Riddle August 9, 2022
    by Stephen Riddle August 9, 2022

    EGFR inhibitors like AstraZeneca’s Tagrisso have been hugely successful in treating EGFR-positive lung cancer, but…

    Read more
  • Pharma News

    AI tissue analysis enables rapid discovery of drug candidates

    by Stephen Riddle August 9, 2022
    by Stephen Riddle August 9, 2022

    AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also…

    Read more
  • Pharma News

    FDA okays ProstatID software for detecting prostate cancer in MRI

    by Stephen Riddle August 9, 2022
    by Stephen Riddle August 9, 2022

    Magnetic resonance imaging (MRI) technology specialist Bot Image has won FDA approval for its artificial…

    Read more
  • Pharma News

    Karuna Therapeutics scores phase 3 win for schizophrenia therapy KarXT

    by Stephen Riddle August 9, 2022
    by Stephen Riddle August 9, 2022

    Karuna Therapeutics has unveiled positive topline results from its phase 3 EMERGENT-2 trial evaluating the…

    Read more
  • Pharma News

    Pfizer vaults into sickle cell market as GBT deal confirmed

    by Stephen Riddle August 8, 2022
    by Stephen Riddle August 8, 2022

    Pfizer’s reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT)  has been…

    Read more
  • Pharma News

    ODM standard for CRF design

    by Stephen Riddle August 8, 2022
    by Stephen Riddle August 8, 2022

    Over the last few years, our industry has become familiar with CDISC standards. This has largely…

    Read more
  • Pharma News

    Bayer bags swift OK for Nubeqa in metastatic prostate cancer

    by Stephen Riddle August 8, 2022
    by Stephen Riddle August 8, 2022

    Bayer has won a key FDA approval to extend the use of its prostate cancer…

    Read more
  • Pharma News

    Digital health app linked to better outcomes in heart failure

    by Stephen Riddle August 8, 2022
    by Stephen Riddle August 8, 2022

    A study of a mobile health app used to support patients hospitalised with heart failure…

    Read more
  • Pharma News

    AZ gets FDA nod for Enhertu in first HER2-low cancer

    by Stephen Riddle August 8, 2022
    by Stephen Riddle August 8, 2022

    The FDA has approved AstraZeneca and Daiichi Sankyo’s Enhertu as the first targeted therapy for…

    Read more
  • Pharma News

    Living the life of a type 2 diabetes patient for a day

    by Stephen Riddle August 8, 2022
    by Stephen Riddle August 8, 2022

    Mark Doyle, co-founder of The Method and creator of the A Life in a Day…

    Read more
  • Pharma News

    Pfizer bid for sickle cell drug developer GBT said to be imminent

    by Stephen Riddle August 8, 2022
    by Stephen Riddle August 8, 2022

    Pfizer is on the brink of announcing a deal to buy Global Blood Therapeutics (GBT)…

    Read more
  • Pharma News

    US Democrats’ blockbuster budget bill could spell big changes for drug prices

    by Stephen Riddle August 5, 2022
    by Stephen Riddle August 5, 2022

    The Inflation Reduction Act of 2022, a sweeping measure that now looks likely to be…

    Read more
  • Pharma News

    Sosei Heptares banks $30m milestone in Neurocrine Bio alliance

    by Stephen Riddle August 5, 2022
    by Stephen Riddle August 5, 2022

    Sosei Heptares has taken another of its partnered G protein-coupled receptor (GPCR) programmes into mid-stage…

    Read more
  • Pharma News

    Bayer tops pharma rankings for diversity, inclusivity

    by Stephen Riddle August 5, 2022
    by Stephen Riddle August 5, 2022

    The largest pharma companies have all set themselves ambitious targets in recent years to improve…

    Read more
  • Pharma News

    Sanofi looks east with €300m Innovent cancer alliance

    by Stephen Riddle August 5, 2022
    by Stephen Riddle August 5, 2022

    Sanofi is making a €300 million investment in Chinese biotech Innovent as part of a…

    Read more
  • Pharma News

    Traditional approaches to growth in biopharma are no longer sustainable

    by Stephen Riddle August 5, 2022
    by Stephen Riddle August 5, 2022

    Over the past 15 years, more than 60% of asset growth among the top 30…

    Read more
  • Pharma News

    Gilead snaps up MiroBio and its checkpoint agonists for $405m

    by Stephen Riddle August 5, 2022
    by Stephen Riddle August 5, 2022

    Less than three years after being spun out of Oxford University, privately-held biotech MiroBio is…

    Read more
  • Pharma News

    Amgen splashes out on ChemoCentryx and its blockbuster hopeful

    by Stephen Riddle August 5, 2022
    by Stephen Riddle August 5, 2022

    Ten months after ChemoCentryx scored an unexpected FDA approval for autoimmune disease therapy Tavneos, Amgen…

    Read more
  • Pharma News

    Realising the promise of genomic testing across oncology

    by Stephen Riddle August 4, 2022
    by Stephen Riddle August 4, 2022

    Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers…

    Read more
  • Pharma News

    NHS unveils screening plan to eliminate hepatitis C virus

    by Stephen Riddle August 4, 2022
    by Stephen Riddle August 4, 2022

    Thousands of people in the UK will be screened for hepatitis C virus in a…

    Read more
  • Pharma News

    Pfizer takes pipeline blow as it abandons cardiomyopathy drug

    by Stephen Riddle August 4, 2022
    by Stephen Riddle August 4, 2022

    Pfizer has stopped development of a drug to treat cardiomyopathy caused by a rare form…

    Read more
  • Pharma News

    AZ, Merck get EU nod for Lynparza as adjuvant breast cancer therapy

    by Stephen Riddle August 4, 2022
    by Stephen Riddle August 4, 2022

    The European Commission has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or…

    Read more
  • Pharma News

    How can the pharma industry address the gap in talent recruitment and development?

    by Stephen Riddle August 4, 2022
    by Stephen Riddle August 4, 2022

    Across the economy, several industries have seen a significant increase in staff turnover due to…

    Read more
  • Pharma News

    Keytruda fluffs its lines in prostate, liver cancer trials

    by Stephen Riddle August 4, 2022
    by Stephen Riddle August 4, 2022

    Two phase 3 trials of Merck & Co’s Keytruda in metastatic castration-resistant prostate cancer (CRPC)…

    Read more
  • Pharma News

    How the WHO hepatitis strategy measures up in the field

    by Stephen Riddle August 3, 2022
    by Stephen Riddle August 3, 2022

    According to the World Health Organization (WHO), approximately 296 million people globally live with hepatitis…

    Read more
  • Pharma News

    New treatments for heart disease

    by Stephen Riddle August 3, 2022
    by Stephen Riddle August 3, 2022

    Heart failure Heart failure is one of the main causes of disability and mortality from…

    Read more
  • Pharma News

    AC Immune tries to resurrect crenezumab with new data delve

    by Stephen Riddle August 3, 2022
    by Stephen Riddle August 3, 2022

    In May, another amyloid targeting drug for Alzheimer’s disease – AC Immune and Roche’s crenezumab…

    Read more
  • Pharma News

    Gilead Sciences’ push into oncology is paying off, as Veklury falters

    by Stephen Riddle August 3, 2022
    by Stephen Riddle August 3, 2022

    Gilead Sciences’ investment in oncology has started to provide a solid return, with sales of…

    Read more
  • Pharma News

    Phase 3 lung cancer fail dents prospects of Ipsen, Servier’s Onivyde

    by Stephen Riddle August 3, 2022
    by Stephen Riddle August 3, 2022

    Ipsen and Servier’s hopes of extending the uses for chemotherapy drug Onivyde have been knocked…

    Read more
  • Pharma News

    Connecting EHR to clinical trials: How to embrace the promise of real-world data

    by Stephen Riddle August 3, 2022
    by Stephen Riddle August 3, 2022

    We all know that real-world data (RWD) from electronic health records (EHR) could boost clinical…

    Read more
  • Pharma News

    Pressure rises on Lucentis, as Coherus biosimilar gets FDA nod

    by Stephen Riddle August 3, 2022
    by Stephen Riddle August 3, 2022

    The US FDA has approved a new biosimilar of Roche and Novartis’ blockbuster ophthalmology therapy…

    Read more
  • Pharma News

    Chinese biotech Sironax raises $200m for RIPK1 pipeline

    by Stephen Riddle August 3, 2022
    by Stephen Riddle August 3, 2022

    Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still…

    Read more
  • 1
  • 2
  • 3
  • …
  • 40

Recent Posts

  • GSK, Sanofi and Haleon ‘facing billions of dollars in Zantac liability’

    August 11, 2022
  • 3rd TIGIT Axis Therapies Summit

    August 11, 2022
  • Novartis’ Pluvicto gets first European approval in GB

    August 11, 2022
  • Challenges and opportunities in the off-patent sector: the pharmaphorum podcast

    August 11, 2022
  • COVID antibody declines prompts call for booster jabs ASAP

    August 11, 2022
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor

@2018 - TopPharmaNews.com. All Right Reserved.